Sanofi Closes Sale of Controlling Stake in Opella to CD&R

MT Newswires Live
2025/05/01

Sanofi (SNY) said Wednesday it has closed the sale of a 50% controlling stake of its consumer healthcare business Opella to private equity firm CD&R for net cash proceeds of around 10 billion euros ($11.35 billion).

The healthcare company said it retains a 48.2% stake in Opella, with investment bank Bpifrance holding the remaining 1.8% stake and joining the board.

Sanofi said it is now a "pure-play biopharma" after the divestment.

The company's shares were up 1.8% in recent trading on Wednesday.

Price: 54.71, Change: +0.99, Percent Change: +1.84

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10